{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:21:10Z","timestamp":1791811270618,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>The incidence of human papillomavirus (HPV)-positive oropharyngeal cancer has increased to epidemic-like proportions in the United States and other industrialized nations. However, geographical variations are notable across the world. While significant progress has been made in the understanding of this disease with respect to its etiology, underlying biology, and pathogenesis, numerous uncertainties persist. The purpose of this review is to thus present some of the controversies and questions surrounding this disease focusing on its unique epidemiology. A selected series of critical points were presented related to the epidemiology, pathogenesis, and diagnosis of HPV-positive oropharyngeal cancer. Interpretive viewpoints were provided after a comprehensive review of the literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>HPV is now estimated to cause approximately 70% of oropharyngeal cancers in the United States and other developed countries. However, in developing countries, the incidence of HPV-positive oropharyngeal cancer is significantly lower. Data has also established that HPV-positive and HPV-negative oropharyngeal cancer represents distinct entities that generally originate in different settings. Since HPV-positive oropharyngeal cancer is increasingly being recognized as a sexually transmitted disease with unique modes of transmission, the epidemiological implications are of practical relevance. The resultant geographical variation in incidence rates among countries across the world is thus believed to be due to differing lifestyles and sexual norms. Although there is currently no role for screening, efforts to promote general awareness particularly among high-risk groups should be prioritized. The development of a novel staging system specific for patients with HPV-positive oropharyngeal cancer also has important ramifications with respect to treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>HPV-positive oropharyngeal cancer is increasingly recognized as a public health problem with a unique worldwide geographical distribution. As the etiology of this disease is increasingly elucidated, efforts to promote awareness and education are warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11912-025-01656-4","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T02:33:29Z","timestamp":1755657209000},"page":"1395-1400","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Epidemiological Trends in the Characterization of Human Papillomavirus Virus-Related Oropharyngeal Cancer: A Global Perspective"],"prefix":"10.1007","volume":"27","author":[{"given":"Allen M.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"1656_CR1","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1200\/JCO.22.02625","volume":"41","author":"AK Chaturvedi","year":"2023","unstructured":"Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the united States. J Clin Oncol. 2023;41:3081\u20138.","journal-title":"J Clin Oncol"},{"key":"1656_CR2","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41571-022-00603-7","volume":"19","author":"M Lechner","year":"2022","unstructured":"Lechner M, Liu J, Masterson L, et al. HPV-associated oropharyngeal cancer: epidemiology, molecular biology, and clinical management. Nat Rev Clin Oncol. 2022;19:306\u201327.","journal-title":"Nat Rev Clin Oncol"},{"key":"1656_CR3","doi-asserted-by":"publisher","first-page":"6598","DOI":"10.1158\/0008-5472.CAN-16-0633","volume":"76","author":"AG Schache","year":"2016","unstructured":"Schache AG, Powell NG, Cuschieri KS, et al. HPV-related oropharynx cancer in the united Kingdom: an evolution in the Understanding of disease etiology. Cancer Res. 2016;76:6598\u2013606.","journal-title":"Cancer Res"},{"key":"1656_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejca.2020.04.027","volume":"134","author":"M Zamani","year":"2020","unstructured":"Zamani M, Gronjoj C, Jensen DH, et al. The current epidemic of HPV-associated oropharyngeal cancer: an 18-year Danish population-based study with 2,169 patients. Eur J Caner. 2020;134:52\u20139.","journal-title":"Eur J Caner"},{"key":"1656_CR5","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1158\/1940-6207.CAPR-19-0098","volume":"12","author":"C Wittekindt","year":"2019","unstructured":"Wittekindt C, Wagner S, Bushnak A, et al. Increasing incidence rates of oropharyngeal squamous cell carcinoma in Germany and significance of disease burden attributed to human papillomavirus. Cancer Prev Res. 2019;12:375\u201382.","journal-title":"Cancer Prev Res"},{"key":"1656_CR6","doi-asserted-by":"publisher","first-page":"e2200259","DOI":"10.1200\/GO.22.00259","volume":"9","author":"S Okerosi","year":"2023","unstructured":"Okerosi S, Mokoh LW, Rubagumya F, et al. Human papillomavirus-associated head and neck malignancies in Sub-Saharan Africa: a systematic review. JCO Global Oncol. 2023;9:e2200259.","journal-title":"JCO Global Oncol"},{"key":"1656_CR7","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.5858\/arpa.2021-0021-OA","volume":"146","author":"G Dapaah","year":"2022","unstructured":"Dapaah G, Hille J, Faquin WC, et al. The prevalence of human papillomavirus-positive oropharyngeal squamous cell carcinoma at one of the largest tertiary care centers in sub-Saharan Africa. Arch Pathol Lab Med. 2022;146:1018\u201323.","journal-title":"Arch Pathol Lab Med"},{"key":"1656_CR8","doi-asserted-by":"publisher","first-page":"e0152828","DOI":"10.1371\/journal.pone.0152828","volume":"11","author":"Oga","year":"2016","unstructured":"Oga EA, Schumaker LM, Alabi BS, et al. Paucity of HPV-related head and neck cancers in Nigeria. PLoS ONE. 2016;11:e0152828.","journal-title":"PLoS ONE"},{"key":"1656_CR9","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.canep.2015.10.015","volume":"39","author":"J Blumberg","year":"2015","unstructured":"Blumberg J, Monjane L, Prasad M, et al. Investigation of the presence of HPV related oropharyngeal and oral tongue squamous cell carcinoma in Mozambique. Cancer Epidemiol. 2015;39:1000\u20135.","journal-title":"Cancer Epidemiol"},{"key":"1656_CR10","doi-asserted-by":"publisher","first-page":"2473974X1881841","DOI":"10.1177\/2473974X18818415","volume":"3","author":"EM Rettig","year":"2019","unstructured":"Rettig EM, Gooi Z, Bardin R, et al. Oral human papillomavirus infection and head and neck squamous cell carcinoma in rural Northwest Cameroon. OTO Open. 2019;3:2473974X18818415.","journal-title":"OTO Open"},{"key":"1656_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.canlet.2020.02.023","volume":"477","author":"LA Buexm","year":"2020","unstructured":"Buexm LA, Soares-Lima S, Brennan P, et al. HPV impact on oropharyngeal cancer patients treated at the largest cancer center from Brazil. Cancer Lett. 2020;477:70\u20135.","journal-title":"Cancer Lett"},{"key":"1656_CR12","first-page":"19","volume":"35","author":"CC Ferreira","year":"2023","unstructured":"Ferreira CC, Rossin PL, dos Santos NA, et al. Human papillomavirus prevalence in oropharynx squamous cell carcinomas in Brazil: a systematic review with meta-analysis. J Adv Med Med Res. 2023;35:19.","journal-title":"J Adv Med Med Res"},{"key":"1656_CR13","doi-asserted-by":"publisher","first-page":"5602","DOI":"10.3390\/cancers13225602","volume":"13","author":"G Mendez Matias","year":"2021","unstructured":"Mendez Matias G, Velazquez-Velazquez C, Castro-Oropeza R, et al. Prevalence of HPV in Mexican patients with head and neck squamous cell carcinoma and identification of potential prognostic biomarkers. Cancers. 2021;13:5602.","journal-title":"Cancers"},{"key":"1656_CR14","doi-asserted-by":"publisher","first-page":"103140","DOI":"10.1016\/j.canep.2022.102140","volume":"78","author":"Y Lu","year":"2022","unstructured":"Lu Y, Xie Z, Luo G, et al. Global burden of oropharyngeal cancer attributable to human papillomavirus by anatomical subsite and geographic region. Cancer Epidemiol. 2022;78:103140.","journal-title":"Cancer Epidemiol"},{"key":"1656_CR15","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/0003489416681582","volume":"126","author":"J Toman","year":"2017","unstructured":"Toman J, Von Larson S, Umeno H, et al. HPV-positive oropharyngeal cancer via p16 immunohistochemistry in Japan. Ann Otol Rhinol Larynol. 2017;126:152\u20138.","journal-title":"Ann Otol Rhinol Larynol"},{"key":"1656_CR16","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/cncr.28015","volume":"119","author":"Y Saito","year":"2013","unstructured":"Saito Y, Yoshida M, Ushiku T, et al. Prognostic value of p16 expression and alcohol consumption in Japanese patients with oropharyngeal squamous cell carcinoma. Cancer. 2013;119:2005\u201311.","journal-title":"Cancer"},{"key":"1656_CR17","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1186\/s12879-023-08759-y","volume":"23","author":"S Yu","year":"2023","unstructured":"Yu S, Zhu Y, He H, et al. Prevalence and risk factors of oral human papillomavirus infection among 4212 health adults in Hebei, China. BMC Infect Dis. 2023;23:773.","journal-title":"BMC Infect Dis"},{"key":"1656_CR18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/cancers16010226","volume":"16","author":"Z Chen","year":"2024","unstructured":"Chen Z, Chan AB, Kam LS, et al. Changes in the incidence and human papillomavirus-positive portion of oropharyngeal squamous cell carcinoma in Hong Kong. Cancers. 2024;16:226.","journal-title":"Cancers"},{"key":"1656_CR19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.47102\/annals-acadmedsg.2020499","volume":"50","author":"EW Fu","year":"2021","unstructured":"Fu EW, Chilangondanahalli N, Bundele MM, et al. Trends in HPV-related oropharyngeal cancers in Singapore. Ann Acad Med Singap. 2021;50:508\u20139.","journal-title":"Ann Acad Med Singap"},{"key":"1656_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.31557\/APJCP.2024.25.1.57","volume":"25","author":"P Saiya","year":"2024","unstructured":"Saiya P, Jantharapattana K, Dechaphunkul A, et al. HPV-related oropharyngeal cancer in Southern Thailand: proportion trend and survival outcome. Asian Pac J Cancer Prev. 2024;25:57\u201364.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1656_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13027-023-00557-0","volume":"18","author":"HP Sathasivan","year":"2023","unstructured":"Sathasivan HP, Davan SP, Chua SM, et al. Findings from a Malaysian multicentre study on oropharyngeal squamous cell carcinoma. Infect Agent Cancer. 2023;18:74.","journal-title":"Infect Agent Cancer"},{"key":"1656_CR22","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1177\/0300891620901768","volume":"106","author":"E Wu","year":"2020","unstructured":"Wu E, An G, Wu R, et al. Prevalence of human papillomavirus in archival head and neck cancer in the Eastern inner Mongolian autonomous region, China. Tumori J. 2020;106:369\u201377.","journal-title":"Tumori J"},{"key":"1656_CR23","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1001\/jamaoto.2013.6732","volume":"140","author":"CB Hess","year":"2014","unstructured":"Hess CB, Rash DL, Daly ME, et al. Competing causes of death and medical comorbidities among patients with human papillomavirus-positive vs human papillomavirus-negative oropharyngeal carcinoma and impact on adherence to radiotherapy. JAMA Otolaryngol Head Neck Surg. 2014;140:312\u20136.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"1656_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/0194599820935853","volume":"164","author":"JM Rotsides","year":"2021","unstructured":"Rotsides JM, Oliver JR, Moses LE, et al. Socioeconomic and Racial disparities and survival of human papillomavirus-associated oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg. 2021;164:131\u20138.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1656_CR25","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1002\/cncr.23742","volume":"113","author":"VB Bernard","year":"2008","unstructured":"Bernard VB, Johnson CJ, Thompson TD, et al. Examining the association between socioeconomic status and potential human papillomavirus-associated cancers. Cancer. 2008;113:2910\u20138.","journal-title":"Cancer"},{"key":"1656_CR26","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/jama.2012.101","volume":"307","author":"ML Gillison","year":"2012","unstructured":"Gillison ML, Broutian T, Pickard RK, et al. Prevalence of oral HPV infection in the united States, 2009\u20132010. JAMA. 2012;307:693\u2013703.","journal-title":"JAMA"},{"key":"1656_CR27","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S0140-6736(13)60809-0","volume":"382","author":"AR Kreimer","year":"2013","unstructured":"Kreimer AR, Campbell CM, Lin HY, et al. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet. 2013;382:877\u201387.","journal-title":"Lancet"},{"key":"1656_CR28","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/cncr.33346","volume":"127","author":"VE Drake","year":"2022","unstructured":"Drake VE, Fakhry C, Windon MJ, et al. Timing, number and type of sexual partners associated with risk of oropharyngeal Caner. Cancer. 2022;127:1029\u201338.","journal-title":"Cancer"},{"key":"1656_CR29","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.3390\/cancers15133356","volume":"15","author":"G Wichmann","year":"2023","unstructured":"Wichmann G, Rudolph J, Henger S, et al. Is high-risk sexual behavior a risk factor for oropharyngeal cancer? Cancers. 2023;15:3356.","journal-title":"Cancers"},{"key":"1656_CR30","unstructured":"HPV Vaccination Recommendations. Centers for Disease Control and Prevention. Atlanta, GA 2021. https:\/\/www.cdc.gov\/vaccines\/vpd\/hpv\/hcp\/recommendations.html. Accessed December 1, 2023."},{"key":"1656_CR31","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1002\/cncr.29538","volume":"121","author":"KR Dahlstrom","year":"2015","unstructured":"Dahlstrom KR, Li G, Hussey C, et al. Circulating HPV DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer. Cancer. 2015;121:3455\u201364.","journal-title":"Cancer"},{"key":"1656_CR32","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1093\/annonc\/mdz138","volume":"30","author":"AR Kreimer","year":"2019","unstructured":"Kreimer AR, Ferreiro-Iglesias A, Nygard M, et al. Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium. Ann Oncol. 2019;30:1335\u201343.","journal-title":"Ann Oncol"},{"key":"1656_CR33","doi-asserted-by":"publisher","first-page":"106644","DOI":"10.1016\/j.oraloncology.2023.106644","volume":"148","author":"RF Shenker","year":"2024","unstructured":"Shenker RF, Razavian NB, D\u2019Agostino RB, et al. Clinical outcomes of oropharyngeal squamous cell carcinoma stratified by human papillomavirus subtype: A systematic review and meta-analysis. Oral Oncol. 2024;148:106644.","journal-title":"Oral Oncol"},{"key":"1656_CR34","doi-asserted-by":"publisher","first-page":"e0009","DOI":"10.5041\/RMMJ.10143","volume":"5","author":"P Joshi","year":"2014","unstructured":"Joshi P, Dutta S, Chaturvedi P, et al. Head and neck cancers in developing countries. Rambam Maimonides Med J. 2014;5:e0009.","journal-title":"Rambam Maimonides Med J"},{"key":"1656_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijsu.2005.12.004","volume":"4","author":"GM Humprhis","year":"2006","unstructured":"Humprhis GM, Ozakinci G. Pscyhological responses and support needs of patients following head and neck cancer. Int J Surg. 2006;4:37\u201344.","journal-title":"Int J Surg"},{"key":"1656_CR36","first-page":"JGO2016006304","volume":"4","author":"RK Cleary","year":"2016","unstructured":"Cleary RK, Cmelak AJ. Evolving treatment paradigms for oropharyngeal squamous cell carcinoma. J Glob Oncol. 2016;4:JGO2016006304.","journal-title":"J Glob Oncol"},{"key":"1656_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.humpath.2019.05.006","volume":"90","author":"R Randen-Brady","year":"2019","unstructured":"Randen-Brady R, Carpen T, Jouhi L, et al. In situ hybridization for high-risk HPV E6\/E7 mRNA is a superior method for detecting transcriptionally active HPV in oropharyngeal cancer. Hum Pathol. 2019;90:97\u2013105.","journal-title":"Hum Pathol"},{"key":"1656_CR38","volume-title":"American joint committee on Cancer staging manual","year":"2017","unstructured":"Amin MB, Edge SB, Greene FL, et al. editors. American joint committee on Cancer staging manual. 8th ed. New York: Springer; 2017.","edition":"8"},{"key":"1656_CR39","first-page":"30871","volume":"275","author":"SJ Sharma","year":"2018","unstructured":"Sharma SJ, Wagner S, Reder HSF, et al. The AJCC\/UICC TNM 8th edition staging for p16-positive oropharyngeal carcinoma: is there space for improvement? Eur Arch Otorhionlaryngol. 2018;275:30871\u20133091.","journal-title":"Eur Arch Otorhionlaryngol"},{"key":"1656_CR40","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.ijrobp.2018.11.046","volume":"103","author":"N Vawda","year":"2019","unstructured":"Vawda N, Banergjee RN, Debenham BJ. Impact of smoking on outcomes of HPV-related oropharyngeal cancer treated with primary radiation or surgery. Int J Radiat Oncol Biol Phys. 2019;103:1125\u201331.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"1656_CR41","doi-asserted-by":"publisher","first-page":"e472","DOI":"10.1016\/S2468-2667(21)00102-X","volume":"28","author":"MB Reitsma","year":"2021","unstructured":"Reitsma MB, Flor LS, Mullany EC, et al. Spatial, Temporal, and demographic patterns in prevalence of smoking, tobacco use, and initiation among young people in 204 countries and territories, 1990\u20132019. Lancet Public Health. 2021;28(6):e472\u2013481.","journal-title":"Lancet Public Health"},{"key":"1656_CR42","first-page":"299","volume":"34","author":"S Elrefaey","year":"2014","unstructured":"Elrefaey S, Massaro MA, Chiocca S, et al. HPV in oropharyngeal cancer: the basics to know in clinical practice. Acta Otorhinolaryngol Ital. 2014;34:299\u2013309.","journal-title":"Acta Otorhinolaryngol Ital"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-025-01656-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-025-01656-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-025-01656-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T09:02:13Z","timestamp":1766826133000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-025-01656-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":42,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1656"],"URL":"https:\/\/doi.org\/10.1007\/s11912-025-01656-4","relation":{},"ISSN":["1534-6269"],"issn-type":[{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"17 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work did not require use of human subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent To Participate"}},{"value":"No patients were used and thus no consent was required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The lead author (AC) affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Transparency Statement"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}